Intercept Pharmaceuticals, Inc.  

New York,  NY 
United States
http://www.interceptpharma.com
  • Booth: 4253

Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases such as primary biliary cirrhosis, also known as primary biliary cholangitis, nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. For more information, please visit Intercept's website: www.interceptpharma.com.


Send Email

Type your information and click "Send Email" to send an email to this exhibitor. To return to the previous screen without saving, click "Reset".


Do you have questions about getting the most from your eBooth? Check the eBooth FAQ.